Background Neonatal-onset multisystem inflammatory disease is characterized by fever,
urticarial rash, aseptic meningitis, deforming arthropathy, hearing loss, and mental retardation. …

Background Tumor necrosis factor (TNF) has a pathogenic role in juvenile rheumatoid
arthritis. We evaluated the efficacy and safety of adalimumab, a fully human monoclonal anti-TNF …

The American College of Rheumatology (ACR) published treatment recommendations for
juvenile idiopathic arthritis (JIA) in 2011 (1). These recommendations represented the first …

Objective There is wide variation in therapeutic approaches to systemic juvenile idiopathic
arthritis (JIA) among North American rheumatologists. Understanding the comparative …

Objective To investigate the characteristics and risk factors of a novel parenchymal lung
disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA). Methods In a …

Objective There is no standardized approach to the initial treatment of polyarticular juvenile
idiopathic arthritis (JIA) among pediatric rheumatologists. Understanding the comparative …

Objective Autoantibodies recognizing 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR)
are associated with statin exposure, the HLA allele DRB1*11:01, and necrotizing …

Background Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatic disease
and a leading cause of childhood disability. The objective of this study was to characterize …

Background The United States pediatric rheumatology workforce is committed to a mission
of providing children access to pediatric rheumatology care. With a limited number and …

… Torok, MD, University of Pittsburgh Medical Center, Pittsburgh, PA; Jenna Tress, BA, The
Children's Hospital of Philadelphia, Philadelphia, PA; Richard K. Vehe, MD, University of …